Device Trial Radar · NCT00922649
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Sep 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
58
Actual
Start
Feb 1, 2008
Primary completion
Dec 1, 2008
Study completion Jan 1, 2009
Sponsor
- Lead sponsor
- Animas CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 17, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Device feasibility
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
16-week, open-label, multi-center pilot study. Insulin pump naïve subjects with type 2 diabetes who are not achieving glycemic targets (screening A1C ≥ 7.0%) on an established regimen of either: 1) ≥ 2 OAs (Cohort A), 2) basal insulin ± OAs (Cohort B), or 3) basal-bolus insulin ± OAs (Cohort C) will initiate basal-bolus therapy with an insulin pump using a rapid-acting insulin analog.
Conditions
- Type 2 Diabetes
Interventions
Insulin Pump therapyDevice
Initiation of Insulin pump therapy in patients on \>2 OAs (Cohort A), basal insulin ± OAs (Cohort B), or basal-bolus insulin ± OAs (Cohort C.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Insulin doses at Week 16Time frame: Week 16
- Ratio of Basal-to-Bolus Insulin Dose at Week 16Time frame: 16 weeks
- Number of daily basal rates at Week 16Time frame: Week 16
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
The Regents of the University of California on behalf of its San Diego campus
La Jolla, California
AMCR Institute, Inc.
San Diego, California
Atlanta Diabetes Associates, Inc.
Atlanta, Georgia
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.